Procter & Gamble Co (P&G) is to acquire the consumer health business of Merck KGaA for about 3.4 billion euros (US$4.21 billion), giving it vitamin brands such as Seven Seas, and greater exposure to Latin American and Asian markets.
P&G, whose stable of brands include Pampers diapers, Gillette razors and Vicks cough and cold products, yesterday said that the acquisition had been agreed upon and would enable it to expand its portfolio of consumer healthcare products.
Merck’s unit also includes vitamin brands such as Femibion, Neurobion and Nasivin.
The purchase price for Merck’s business suggests that the German company climbed down from price demands of as much as 4 billion euros, which sources said deterred initial suitors such as Nestle SA, Perrigo Co and Stada owners Bain Capital Private Equity LP and Cinven Partners LLP.
The price still implied a valuation of 4.7 times sales and about 19 times operating profit for the business, at the high end of recent deals seen in the sector, Morgan Stanley analyst Vincent Meunier said.
“This will help [Merck] focus on its pharma unit and refurbish its pipeline,” he said.
P&G said it would also terminate its consumer care joint venture with Teva Pharmaceutical Industries Ltd, PGT Healthcare LLP, on July 1, because their strategies are no longer aligned.
Merck said the divestment of its consumer health business does not change its goal of keeping net sales of its established prescription drugs, such as Erbitux against cancer and multiple sclerosis treatment Rebif, organically stable until 2022.
It would issue guidance for this year to reflect the sale of the consumer healthcare business when it publishes first-quarter financial results on May 15, it said in presentation slides.
It expects the sale to P&G to close by the fourth quarter, Merck said.
About 3,300 Merck employees, mainly from the consumer health unit, could move to P&G upon completion of the transaction.
As part of the deal, P&G would buy a majority stake in the German company’s Indian consumer health business, Merck Ltd, and subsequently make a mandatory tender offer to minority shareholders.
The deal does not yet include Merck’s French consumer health business, for which P&G has made a binding offer, Merck said.
Intel Corp chief executive officer Lip-Bu Tan (陳立武) is expected to meet with Taiwanese suppliers next month in conjunction with the opening of the Computex Taipei trade show, supply chain sources said on Monday. The visit, the first for Tan to Taiwan since assuming his new post last month, would be aimed at enhancing Intel’s ties with suppliers in Taiwan as he attempts to help turn around the struggling US chipmaker, the sources said. Tan is to hold a banquet to celebrate Intel’s 40-year presence in Taiwan before Computex opens on May 20 and invite dozens of Taiwanese suppliers to exchange views
Application-specific integrated circuit designer Faraday Technology Corp (智原) yesterday said that although revenue this quarter would decline 30 percent from last quarter, it retained its full-year forecast of revenue growth of 100 percent. The company attributed the quarterly drop to a slowdown in customers’ production of chips using Faraday’s advanced packaging technology. The company is still confident about its revenue growth this year, given its strong “design-win” — or the projects it won to help customers design their chips, Faraday president Steve Wang (王國雍) told an online earnings conference. “The design-win this year is better than we expected. We believe we will win
Chizuko Kimura has become the first female sushi chef in the world to win a Michelin star, fulfilling a promise she made to her dying husband to continue his legacy. The 54-year-old Japanese chef regained the Michelin star her late husband, Shunei Kimura, won three years ago for their Sushi Shunei restaurant in Paris. For Shunei Kimura, the star was a dream come true. However, the joy was short-lived. He died from cancer just three months later in June 2022. He was 65. The following year, the restaurant in the heart of Montmartre lost its star rating. Chizuko Kimura insisted that the new star is still down
While China’s leaders use their economic and political might to fight US President Donald Trump’s trade war “to the end,” its army of social media soldiers are embarking on a more humorous campaign online. Trump’s tariff blitz has seen Washington and Beijing impose eye-watering duties on imports from the other, fanning a standoff between the economic superpowers that has sparked global recession fears and sent markets into a tailspin. Trump says his policy is a response to years of being “ripped off” by other countries and aims to bring manufacturing to the US, forcing companies to employ US workers. However, China’s online warriors